peoplePerson
Kenneth C. Anderson
Translated bortezomib and lenalidomide from bench to bedside, helping turn myeloma from a two-year to a decade-plus disease.
Myeloma pioneer whose laboratory and clinical work underpinned the approval of bortezomib, lenalidomide and later novel agents; long-time director of the Lipper Myeloma Center.
Role
Kraft Family Professor of Medicine; Director, Jerome Lipper Multiple Myeloma Center
Institution
Specialisms
Multiple myelomaProteasome inhibitorsImmunomodulatory drugs
Profiles
| Title | Journal | Year |
|---|---|---|
| Bortezomib or high-dose dexamethasone for relapsed multiple myeloma | New England Journal of Medicine | 2005 |